Clear Street’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Clear Street’s Portfolio BIOSU Stock Details BIOSU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-19,249	Closed	-$209K	–	1173
2023 Q3	$209K	Buy	19,249 +18,994	+7,449%	+$205K	﹤0.01%	164
2023 Q2	$2.74K	Sell	255 -882	-78%	-$9.36K	﹤0.01%	912
2023 Q1	$11.9K	Buy	+1,137	New	+$11.8K	﹤0.01%	474
2022 Q3	–	Sell	-226	Closed	-$2K	–	1363
2022 Q2	$2K	Buy	+226	New	+$2.26K	﹤0.01%	883

Clear Street's BIOSU Position: Q4 2023 in Review

Clear Street sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q4 2023, closing a stake of 19,249 shares — an estimated $209K sold.

Clear Street first reported a position in BIOSU in Q2 2022 and held it in 4 quarters. The position peaked at $209K in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOSU as of Q4 2023.

Clear Street reported no remaining BioPlus Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
Clear Street sold 19,249 BioPlus Acquisition Corp. Unit shares in Q4 2023, an estimated $209K.
Clear Street first reported a position in BioPlus Acquisition Corp. Unit in Q2 2022 and held it in 4 quarters.
Clear Street's BioPlus Acquisition Corp. Unit position peaked at $209K in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q4 2023.

Based on Clear Street's 13F filing for Q4 2023, filed 14 Feb 2024.